In a reassuring statement to the public, the Food and Drug Administration (FDA) has confirmed the safety of seafood imported from Japan, emphasizing rigorous testing for radioactivity. This announcement comes as global concerns mount over the release of treated water from the Fukushima nuclear power plant, which suffered catastrophic damage from a tsunami in 2011.
Deputy Secretary-General of the FDA, Lertchai Lertvut, underscored the implementation of stringent safety protocols since the Fukushima plant initiated the release of treated radioactive water into the Pacific Ocean on August 24. To ensure consumer safety, the FDA has conducted thorough examinations on 75 samples of “at-risk” seafood, which includes squid, mollusks, and crabs, with a particular focus on their cesium-134 and cesium-137 content.
Lertchai revealed that, thus far, results from the analysis of 42 out of the 73 samples have not shown any traces of radioactivity exceeding international standards. The examination of the remaining 33 samples remains ongoing, with continuous scrutiny.
The Deputy Secretary-General of the FDA has provided a firm assurance to the public that in the event of any contaminated samples being detected with radioactivity, the affected seafood stocks will be promptly disposed of, and importation will be immediately suspended. He also emphasized that the FDA has adopted comprehensive measures to guarantee that all imported seafood remains free from radioactive contamination. Consumer safety remains a paramount concern for the FDA, which is committed to upholding strict standards and ensuring the safety of seafood imported from Japan.
 has confirmed the safety of seafood imported from Japan, emphasizing rigorous testing for radioactivity.){kind=link}